Home » Topics » Neurology/psychiatric, BioWorld Science

Neurology/psychiatric, BioWorld Science
RSS

Novel histamine H3 receptor antagonists revealed by Lilly

Nov. 16, 2005

AMG-0347: a novel, potent and selective TRPV1 antagonist

Nov. 16, 2005

JDY-8112 protects dopaminergic neurons against inflammatory damage

Nov. 16, 2005

M-43068: A novel analgesic agent with reduced side effect profile

Nov. 16, 2005

Promising antinociceptive effects of a novel P2X7 receptor antagonist from Abbott

Nov. 16, 2005

Phase I study for NGX-424 for intractable pain

Nov. 16, 2005

Phase I study for EVT-101

Nov. 16, 2005

ABT-894 begins phase I multidose trial for neuropathic pain

Nov. 16, 2005

Good safety profile reported for single-dose ACP-104 in patients with schizophrenia

Nov. 15, 2005

Sildenafil improves performance in rodent models of cognitive decline

Nov. 15, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...